info icon

This is a non-core endpoint: only basic statistics are computed.

Carcinoma in situ of bronchus and lung

CD2_INSITU_BRONCHUSLUNG_EXALLC

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

None

-

2. Check conditions

  • not C3_BRONCHUS_LUNG
-

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 D02.2&
  • Hospital discharge: ICD-9 2312
  • Cause of death: ICD-10 D02.2&
  • Cause of death: ICD-9 2312
  • Cancer registry: Topography ICD-O-3 C34
  • Cancer registry: Morphology ICD-O-3 ANY
  • Cancer registry: Behaviour codes 2

3 out of 7 registries used, show all original rules.

-

4. Check minimum number of events

None

-

5. Include endpoints

None

-

6. Filter based on genotype QC (FinnGen only)

None

-

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF9
Parent code in ICD-10
D02
Name in latin
Carcinoma in situ mammae

Case counts by codes

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population - - -
Only index persons - - -
Unadjusted period prevalence (%)
Whole population - - -
Only index persons - - -
Median age at first event (years)
Whole population - - -
Only index persons - - -

-FinnGen-

Key figures

All Female Male
Number of individuals 44 16 28
Unadjusted period prevalence (%) 0.01 0.01 0.01
Median age at first event (years) 69.10 68.65 69.36

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

No data available

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
15
8
27.43
11.22
1.5
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
28
92
6.62
8.91
2.9
1.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
21
61
5.67
7.42
3.3
2.0
—
—
—
0
0
(3002256) Pathology report gross observation
12
25
6.22
5.89
1.5
1.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
30
136
4.79
5.80
5.3
3.6
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
30
138
4.69
5.64
10.8
7.9
inr
1.3
1.3
—
5
40
(3024561) Albumin [Mass/volume] in Serum or Plasma
29
134
4.41
5.33
6.4
3.7
g/l
35.1
34.8
0.13
29
126
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
5
0
+∞
5.30
1.2
0.0
—
—
—
0
0
(4010399)
12
29
5.31
4.99
1.3
1.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
7
5
16.24
4.74
1.3
1.0
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
22
92
3.78
4.48
3.6
3.9
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
8
10
9.46
4.26
1.4
1.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
22
95
3.63
4.22
3.5
1.9
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
31
168
3.86
4.18
11.9
4.2
umol/l
19.8
12.9
0.34
31
157
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
8
12
7.86
3.86
3.5
3.2
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
39
271
4.85
3.66
14.8
5.0
u/l
75.4
73.7
0.12
39
245
(3013650) Neutrophils [#/volume] in Blood by Automated count
32
188
3.57
3.58
9.7
6.3
e9/l
4.6
4.5
0.02
32
159
(3042936) Bacteria identified in Isolate by Culture
14
53
3.41
3.16
1.7
1.8
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
7
12
6.70
3.15
2.1
1.8
—
—
—
0
0
(3018418) pH of Serum or Plasma
21
103
2.99
3.08
3.7
3.7
ph
7.4
7.4
—
6
12
(3019225) pH of Specimen
10
31
3.88
2.98
4.1
2.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
14
56
3.20
2.87
4.1
5.3
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
24
131
2.83
2.84
2.1
3.0
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
5
6
9.18
2.82
1.0
1.7
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
5
7
7.86
2.61
2.0
1.7
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
25
150
2.54
2.33
4.1
5.3
%
62.5
57.6
1.22
25
136
(3022096) Basophils/100 leukocytes in Blood
24
143
2.49
2.25
4.7
5.2
%
0.7
0.6
0.45
24
126
(3006504) Eosinophils/100 leukocytes in Blood
24
148
2.37
2.03
4.5
5.3
%
3.2
2.9
0.37
24
133
(3019069) Monocytes/100 leukocytes in Blood
24
148
2.37
2.03
4.7
5.6
%
9.5
8.5
0.80
24
134
(42870588) Differential panel, method unspecified - Blood
20
114
2.38
2.01
3.4
4.9
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
11
47
2.79
1.96
1.1
1.7
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
5
12
4.55
1.87
9.8
2.8
%
1.6
1.6
—
5
12
(3033658) Prothrombin time (PT) actual/Normal
15
77
2.44
1.87
4.9
3.4
%
87.2
84.9
0.19
15
77
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
6
18
3.69
1.81
3.2
2.5
g/l
0.2
0.2
—
6
13
(3013826) Glucose [Moles/volume] in Serum or Plasma
30
211
2.33
1.79
8.4
4.6
mmol/l
7.5
7.0
0.88
30
192
(3007930) Methemoglobin/Hemoglobin.total in Blood
5
13
4.19
1.76
9.8
2.7
%
0.8
1.0
—
5
13
(3037467) Urinalysis macro (dipstick) panel - Urine
32
233
2.37
1.73
5.2
4.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
6
20
3.30
1.64
18.7
8.1
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
8
33
2.73
1.63
9.6
11.0
g/l
113.9
125.2
—
8
33
(3003396) Base excess in Arterial blood by calculation
9
40
2.56
1.51
15.9
9.9
mmol/l
3.9
1.9
—
9
33
(3018095) Leukocytes [#/volume] in Urine
20
128
2.03
1.42
2.6
3.5
e6/l
573.6
32.3
0.48
15
87
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
6
23
2.85
1.42
5.2
5.1
mmol/l
1.2
1.2
—
6
16
(40768797) Stomach Pathology biopsy report
9
44
2.31
1.37
1.6
1.1
—
—
—
0
0
(3012544) pH of Venous blood
8
36
2.49
1.32
2.3
3.6
—
—
—
0
0
(3019060) Gas panel - Arterial blood
6
25
2.61
1.29
9.5
4.6
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
9
46
2.20
1.12
2.0
1.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
7
33
2.33
1.11
1.6
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
7
33
2.33
1.11
1.6
1.8
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
20
141
1.77
0.99
11.7
9.0
e9/l
0.0
0.0
0.47
14
106
(36304419) Bacteria [Presence] in Urine
15
97
1.83
0.98
2.5
2.7
—
—
—
0
0
(3000991) Gas panel - Venous blood
6
27
2.41
0.98
16.0
12.6
—
—
—
0
0
(3000492) Spirometry study
6
30
2.15
0.91
1.2
1.6
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
8
45
1.95
0.90
1.8
3.2
g/l
2.4
2.2
—
8
39
(3041096) Erythrocytes [Presence] in Urine by Automated
13
83
1.80
0.87
6.8
3.9
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
17
118
1.72
0.87
2.8
2.9
ug/l
109.1
156.3
0.56
17
107
(3027945) Reticulocytes/100 erythrocytes in Blood
7
42
1.79
0.72
2.1
2.3
%
1.7
1.5
—
7
37
(3036481) Cortisol [Moles/volume] in Serum or Plasma
5
27
1.96
0.71
2.6
1.5
nmol/l
441.0
313.7
—
5
22
(3022948) Iron [Moles/volume] in Serum or Plasma
8
52
1.66
0.64
1.9
3.0
umol/l
8.0
13.2
—
8
44
(3009542) Hematocrit [Volume Fraction] of Blood
26
304
0.65
0.63
33.9
14.4
%
36.6
39.7
0.56
16
197
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
0
21
0.00
0.62
0.0
2.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
11
78
1.55
0.49
1.4
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
32
352
0.67
0.46
5.5
5.9
mmol/l
2.4
2.6
0.65
27
318
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
20
163
1.42
0.46
2.5
2.2
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
5
31
1.69
0.45
1.2
7.1
mmol/l
9.1
11.5
—
5
31
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
0
15
0.00
0.42
0.0
1.7
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
0
16
0.00
0.42
0.0
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
0
16
0.00
0.42
0.0
4.4
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
0
16
0.00
0.42
0.0
1.0
—
90.4
—
0
7
(3020564) Creatinine [Moles/volume] in Serum or Plasma
39
365
1.60
0.40
37.0
15.0
umol/l
87.2
83.9
0.27
39
365
(40761535) Cells panel - Urine sediment
5
36
1.44
0.39
4.8
3.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
16
128
1.39
0.39
7.1
4.2
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
31
340
0.70
0.39
5.0
5.2
mmol/l
4.2
4.4
0.46
25
310
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
20
167
1.36
0.38
2.2
1.9
pmol/l
108.1
91.8
0.78
14
88
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
31
339
0.71
0.37
5.2
5.2
mmol/l
1.4
1.5
0.04
26
305
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
30
329
0.72
0.36
4.8
4.5
mmol/l
1.2
1.2
0.35
24
294
(3007853) Bacteria identified in Skin by Aerobe culture
6
45
1.38
0.35
1.2
1.8
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
14
113
1.35
0.32
4.9
3.0
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
38
358
1.45
0.27
28.8
11.7
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
36
340
1.32
0.24
7.0
6.9
mmol/mol
42.2
41.3
0.20
31
311
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
5
38
1.36
0.24
2.8
3.6
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
5
41
1.25
0.23
2.2
2.2
ug/l
2.6
9.8
—
5
33
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
11
90
1.30
0.22
7.5
3.3
ng/l
12.9
182.1
1.36
11
74
(1761482) Bacteria [#/volume] in Urine by Culture
0
11
0.00
0.21
0.0
4.7
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(4094501)
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
0
12
0.00
0.21
0.0
1.9
—
22.1
—
0
7
(3045414) Leukocytes [Presence] in Urine
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
0
12
0.00
0.21
0.0
3.2
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
19
168
1.23
0.20
9.3
5.5
estimate
0.0
0.0
—
6
21
(3023103) Potassium [Moles/volume] in Serum or Plasma
39
375
1.35
0.18
35.7
15.7
mmol/l
4.0
4.0
0.33
39
359
(3019550) Sodium [Moles/volume] in Serum or Plasma
39
373
1.40
0.18
35.7
15.7
mmol/l
138.7
139.8
1.09
39
357
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
39
371
1.45
0.18
19.1
9.0
u/l
23.8
24.5
0.15
39
348
(40758558) Short blood count panel - Blood
11
92
1.26
0.18
4.5
4.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
19
171
1.20
0.16
6.2
3.9
estimate
0.0
0.0
—
5
18
(1761868) Lipid panel - Serum or Plasma
9
107
0.80
0.15
4.4
3.3
—
—
—
0
0
(3013512) EKG study
12
105
1.20
0.13
3.9
3.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
18
164
1.17
0.12
6.5
3.9
estimate
0.0
0.0
—
6
21
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
5
47
1.07
0.10
3.0
4.9
—
33.8
—
0
29
(3020682) Albumin/Creatinine [Ratio] in Urine
13
143
0.87
0.09
4.3
4.1
mg/mmol
0.7
7.8
—
6
91
(3010813) Leukocytes [#/volume] in Blood
39
379
1.25
0.09
43.6
18.6
e9/l
7.3
6.7
1.13
39
363
(3007461) Platelets [#/volume] in Blood
39
379
1.25
0.09
43.6
18.6
e9/l
242.2
235.4
0.29
39
365
(3026361) Erythrocytes [#/volume] in Blood
39
379
1.25
0.09
43.4
18.7
e12/l
4.3
4.5
1.49
39
360
(3024731) MCV [Entitic volume]
39
379
1.25
0.09
43.4
18.6
fl
92.5
91.5
0.66
39
369
(3035941) MCH [Entitic mass]
39
379
1.25
0.09
43.3
18.5
pg
30.7
30.5
0.30
39
369
(3000963) Hemoglobin [Mass/volume] in Blood
39
379
1.25
0.09
45.1
18.8
g/l
131.4
137.1
1.50
39
368
(3044889) 12 lead EKG panel
28
270
1.10
0.05
5.9
4.3
—
—
—
0
0
(3015736) pH of Urine
13
133
0.97
0.00
6.8
3.9
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
13
132
0.98
0.00
3.2
3.2
mmol/l
8.0
7.6
—
7
108
(3012516) Albumin [Mass/volume] in Urine
13
132
0.98
0.00
3.2
3.1
mg/l
7.9
62.3
—
6
86
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
5.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
0
5
0.00
0.00
0.0
1.8
—
4.1
—
0
5
(3042111) Morphology [Interpretation] in Bone marrow Narrative
0
5
0.00
0.00
0.0
5.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
0
5
0.00
0.00
0.0
1.8
—
107.4
—
0
5
(42529406) Shigella sp [Presence] in Stool by Culture
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.6
—
10.1
—
0
5
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
5
50
1.00
0.00
3.2
6.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
9
0.00
-0.00
0.0
1.9
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
0
9
0.00
-0.00
0.0
1.6
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint CD2_INSITU_BRONCHUSLUNG_EXALLC and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have CD2_INSITU_BRONCHUSLUNG_EXALLC.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

Index endpoint: CD2_INSITU_BRONCHUSLUNG_EXALLC – Carcinoma in situ of bronchus and lung

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data